Latest news
BI-1808 Receives FDA Fast Track Designation in Ovarian Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 20:14:04 GMTBioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Ovarian Cancer - ca.finance.yahoo.comca.finance.yahoo.com · Fri, 07 Aug 2026 09:20:00 GMTSenex Biotech's 'CX213' Receives FDA Fast Track Designation - asiae.co.krasiae.co.kr · Fri, 07 Aug 2026 02:28:27 GMTAravax's PVX108 Receives FDA Fast Track Designation for Peanut Allergy - HCPLiveHCPLive · Tue, 04 Aug 2026 15:10:09 GMTCema-Cel Receives FDA RMAT, Fast Track Designations in First-Line LBCL - CancerNetworkCancerNetwork · Thu, 30 Jul 2026 15:07:19 GMTAspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson's Disease - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMTAllogene's Cema-Cel Receives FDA RMAT and Fast Track Designations for First-Line LBCL Consolidation - BioPharm InternationalBioPharm International · Wed, 29 Jul 2026 17:22:39 GMTAllogene Reports No Minimal Residual Disease in 7 of 12 Cema-Cel Patients - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT